Another Drug Price Increase this Year
This is the second time this year that Pfizer has increased the list prices of its drugs in United States.
Read More
Part D/Prescription Drugs
Federal and State Agencies Watching Patient Groups
The Department of Health and Human Services (HHS) and the U.S. attorneys for both Southern District of New York and
Read MorePharma Fights Back
Jim Greenwood, chief executive officer of the Biotechnology Innovation Organization, said at a recent convention held in San Francisco, “our
Read MoreSynthetic Designer Drugs
The U.S. Drug Enforcement Administration head, Chuck Rosenberg, advised a U.S. Senate committee due to the “clunky and cumbersome” process
Read MoreWhy Do the Prices of Old Drugs Keep Going Up?
U.S. Senators Susan Collins (R-ME) and Claire McCaskill (D-MO) wrote to several drug makers asking them to explain their pricing
Read MoreFDA Eases Paperwork To Help Some Patients Get Experimental Drugs
(By Rachel Bluth for Kaiser Health News) The Food and Drug Administration removed an obstacle from of its “compassionate use”
Read MoreThe Green Mountain State is the First
In an effort to force accountability to the pharmaceutical industry, Vermont is the first state to require drug makers to
Read MoreFlorida Stores Help Consumers Buy Imported Drugs Despite Federal Ban
(By Phil Galewitz for Kaiser Health News) LAKELAND, Fla. — A hardy market for imported low-cost prescription drugs has taken
Read MorePublic Opinion versus Science
In David Gortler a former Federal Drug Administration (FDA) medical officer and senior medical analyst, commentary states “I don’t always
Read MoreT-cell Therapies Hopefully Soon
Both Kite Pharma Inc. and Juno Therapeutics Inc., announced Saturday at the annual meeting of the American Society of Clinical
Read More